Law360, New York (January 28, 2015, 3:47 PM EST) -- Device giants C.R. Bard Inc. and Johnson & Johnson unit Ethicon Inc. face bellwether trials in the next few months over their pelvic mesh devices, Pfizer Inc. prepares to defend Lipitor in the first multidistrict litigation bellwether over the cholesterol drug, and Engle tobacco trials proceed in some unusual cases. Here are the product liability showdowns to watch this year.
Pelvic Mesh Litigation
The first half of 2015 will see bellwether trials in the consolidated pelvic mesh cases in West Virginia. On Feb. 18, C.R. Bard will defend its Avaulta line of transvaginal mesh implants from claims by plaintiff Debra Wise that...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!